Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
JAMA NETWORK OPEN(2023)
摘要
This cohort study uses published clinical trial data to assess long-term survival of patients with metastatic urothelial carcinoma who are treated with immune checkpoint inhibitors.
更多查看译文
关键词
urothelial cancer,immune checkpoint inhibitors,long-term
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要